Article

seattletimes.com on 2016-07-12 16:49

Sage Therapeutics surges on postpartum depression drug study

NEW YORK (AP) — A drug to treat severe postpartum depression showed positive results in a mid-stage study, sending shares developer Sage Therapeutics ...

Related news

Sage Therapeutics surges on postpartum depression drug study wkrg.com
Massachusetts , Cambridge
New Drug Eases Postpartum Depression In Victory For Tiny Sage Therapeutics Forbes
Cambridge
Sage Therapeutics to seek approval of postpartum depression drug after trial win bizjournals.com
MSage Therapeutics shares surge 45% on positive trail of postpartum depression drug marketwatch.com
Postpartum depression drug OK’d nwaonline.com
Massachusetts , Yonkers , New York , Dallas
MSage Therapeutics stock surges 50% on positive trial results in postpartum depression marketwatch.com
BSage Stock Rises on Postpartum Depression Drug Data3 min read barrons.com
FDA approves first postpartum depression pill seattletimes.com
Massachusetts , Yonkers , New York
Pill for postpartum depression by Cambridge's Sage succeeds in late-stage trial bizjournals.com
Cambridge , Pill unter dem Bache
US approves first pill to treat postpartum depression Al Jazeera
Massachusetts , Cambridge , United States
Sage Therapeutics gains $220M in value as depression drug clears trial hurdle bizjournals.com
Phase 2 , Kendall Square , Cambridge
Sage Therapeutics asks FDA to approve lead drug for postpartum depression bizjournals.com
The First Pill for Postpartum Depression Is Almost Here Wired.com
Massachusetts , New York , United States , Pill unter dem Bache
FDA approves first pill to treat postpartum depression staradvertiser.com
Massachusetts , Yonkers , New York
FDA approves first drug specifically for postpartum depression Washington Post
Cambridge , United States
Adele on her postpartum depression CNN
New Beginnings , England
A peek at postpartum depression hl.nwaonline.com
Toohil legislation tackles postpartum depression standardspeaker.com
Pennsylvania , Butler